Oxymorphone IR
Drug5 mg
NCT Number: NCT00904085
The purpose of this study was to compare the analgesic efficacy of 5 mg oxymorphone IR with placebo in patients with mild to moderate pain following outpatient knee arthroscopy.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 3
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
5 mg
Time frame: 2 months
Looking for future studies?
Notify MeEndo USA Inc., a Keenova Therapeutics Company
Industry
A Randomized, Double-blind Evaluation of the Analgesic Efficacy and Safety of a Low Dose Oxymorphone Immediate Release in Patients Following Ambulatory Arthroscopic Knee Surgery
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01300377
Neurologic Manifestations, Pain
Dallas, Texas, United States
View Trial DetailsNCT03176667
Neurologic Manifestations, Pain
Hamilton, Ontario, Canada
View Trial DetailsNCT05898087
Gigantomastia, Macromastia
Farmington, Connecticut, United States
View Trial DetailsNCT01307215
Neurologic Manifestations, Pain
Hamilton, Ontario, Canada
View Trial Details